yeah, you can't really argue the discount.
it's a 40M investment.
21c leading into phase 2 results is a huge sign of confidence.
especially from one of the card runners in the US for biotech plays .....
look at some they've backed. not to mention the 8 billion to Uber - tech sector.
I'm just glad to see they've moved up, expanded, locked in a very solid firm. I'm happy. if the SP takes a hit, I'll be buying more. it's a huge sign of confidence to have these guys onboard in a period of a biotech specs lifecycle that is usually the most turbulent.
as said in my previous posts regarding the risks associated with phase 2, how BOT has derisked with results, they've not just derisked further by getting placement by one of the leading biotech funds in the USA.
I'm happy. A CR is never nice, but this is something I can stomach well. well done BOT. let's wait for the Ann ....
yeah, you can't really argue the discount. it's a 40M...
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $1.395M | 3.870M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 266249 | 5 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |